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Abstract
Purpose—Cancer epidemiology is challenging in developing nations, in the absence of reliable
pathology-based cancer registries. Clinical experience suggests that the incidence of gastric cancer
is high in Honduras, in contrast to the limited available national statistics at the time of study
initiation (IARC GLOBOCAN 2002: males 15.2, females 10.8). We estimate the incidence of
gastric cancer for Honduras using an endoscopy registry as a complimentary resource.
Methods—We conducted a retrospective analysis of incident noncardia gastric adenocarcinoma
cases in Western Honduras for the period 2000–2009. This region is well circumscribed
geopolitically with a single district hospital and established referral patterns, to provide a unique
epidemiological niche to facilitate estimation of incidence rates. A prospective, comprehensive
database of all endoscopy procedures from this hospital was utilized at the primary data source.
The catchment area for gastroenterology services for the at-risk population was validated by
calculating the overall endoscopy utilization rates for each municipality in western Honduras.
Incident cases of gastric adenocarcinoma were determined by the endoscopic diagnosis. Pathology
services are not financed by the Ministry of Health, and histology data was incorporated when
available. Population statistics were obtained from the Honduras National Statistics Institute
(INE). Age standardized incidence rates (ASIRs) were calculated using world standard population
fractions.
Results—The catchment area for Western Honduras was validated with the municipality
threshold of 30 endoscopies per 106 person-years, with inclusion of a total of 40 municipalities. In
the Western Honduras catchment area, there were 670 incident cases (439 M, 231 F) of noncardia
gastric adenocarcinoma during the study decade 2000–2009. Notably, 67 (10.0%) and 165
(24.6%) of cases were under the ages of 45 and 55, respectively. The case-finding rate was 5.1
endoscopies performed for each new diagnosis of gastric cancer. The ASIRs for the decade were
30.8 for males and 13.9 for females. Clinically, 60.3% of gastric cancers were Borrmann type 3
(ulcerated mass), and evidence of advanced disease with pyloric obstruction was common
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(35.2%). Subtypes by the Lauren classification were distributed among diffuse (56%), intestinal
(34%) and indeterminate (9.9%), in subjects with available pathology (526/670).
Conclusions—The endoscopy procedure registry may serve as a complimentary data resource
for gastric cancer incidence estimation in resource-limited nation settings wherein pathology
services and cancer registries are absent. The results remain an underestimation in this setting due
to the challenges of access-to-care and related factors. The methodology helps to more fully
characterize the high incidence of gastric cancer in western Honduras and this region of Central
America, and demonstrate the need for additional epidemiology research and interventions
focused on prevention and treatment.
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INTRODUCTION
Gastric adenocarcinoma is the second leading cause of global cancer mortality and the
leading cause of infection-associated cancer mortality, with nearly one million incident
cases annually [1–3]. It is projected to rise from fourteenth into the top ten in all-cause
mortality in the near term, primarily due to growing and aging populations in the high
incidence areas, including western Latin America and eastern Asia [2,4]. Gastric cancer
demonstrates marked geographic variability, both regionally and within countries, which
may relate to differences in host response and genotypes, H. pylori strain virulence, diet, and
environmental factors [5–7]. The geographic variability affords the opportunity for focused
scientific investigation and for targeted prevention programs.
In Latin America, at time of the initiation of the current study, the published International
Agency for Research on Cancer (IARC, GLOBOCAN 2002) age-standardized incidence
rates per 100,000 population (ASIRs) for gastric cancer ranged from 13 to 46 cases and 5 to
31 per 100,000 for males and females, respectively [8]. The highest rates were reported in
Chile, Peru, Ecuador, Colombia and Costa Rica. It is worth noting that these nations
represent middle income countries (MICs) in Latin America, suggesting that the lower
incidence rates in low income countries (LICs) may suffer from the absence of data and
under-reporting, rather than lack of cancer burden [9]. It is well known that cancer
epidemiology is problematic in developing nations due to limited resources, infrastructure,
and reliable national cancer registries [10]. In addition, the Ministries of Health (MOH) in
resource-limited nations often prioritize metrics related to infectious diseases and maternal-
child health, and also are unable to finance core services such as pathology, which are
critical for cancer registries. Bray and colleagues, in their review of the global cancer
burden, noted a lack of population-based cancer registries in 34 of 184 countries examined,
of which, 32 were developing nations; vital statistics systems were also lacking in 88
countries (85 were developing nations) [11].
Honduras is representative of a developing nation in Latin America, wherein the gastric
cancer burden is high based upon clinical experience, which stands in contrast with the
limited available national statistics. Honduras, and neighbors Guatemala, El Salvador, and
Nicaragua, are four of the six nations in Latin America with low global human development
indices [11]. At the time of initiation of this study, in 2002, the IARC estimated gastric
cancer ASIRs for Honduras of 15.2 and 10.8 per 100,000 person years for males and
females, respectively [8]. These rates were primarily imputed in models based upon country
registries in the region. In addition, the Honduras National Cancer Center (Emma Romero
de Callejas) network of hospitals reported only 112 total gastric cancer cases in the 7-year
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period from 1998–2004, the most recent national statistics at the time. We suggest that these
previous estimates represent a significant underestimation [10].
The western region of Honduras provides a unique epidemiological niche to facilitate
accurate estimation of the incidence of gastric cancer for Honduras, and its Central
American neighbors. This rural region, with a population of over one half million people, is
well-circumscribed by geopolitical boundaries. A single district hospital has provided the
only endoscopy services in western Honduras, with a well-defined catchment area, and an
established referral pattern. In sum, this hospital diagnoses and cares for the majority of
gastric cancer cases that present for medical care. Our aim was to provide an estimation of
the burden of gastric cancer in Honduras during the 10-year period from 2000–2009, by
incorporating the detailed endoscopy registry as a complimentary resource.
METHODS
Study design and setting
We conducted a retrospective analysis of incident cases of noncardia gastric
adenocarcinoma in western Honduras for the period from 2000–2009, using the existing data
sources described herein. In brief, the principal sources included the endoscopy utilization
database, the gastric cancer and pathology database from the Ministry of Health (regional
hospital), and the national census statistics. The upper endoscopy utilization rates in the
region were calculated to demarcate and validate the referral area. The incident case and
population data were used to calculate the annual ASIRs for the western region and each of
its political sub-divisions. The study was approved by the institutional review boards of the
University of North Carolina, Chapel Hill, and the Western Regional Hospital.
The Western Regional Hospital (WRH) of the Ministry of Health, is located in Santa Rosa
de Copán (2001 population, 39,000) in the state (departamento) of Copán, serving western
Honduras. This triangular rural region is delineated by mountains to the east, and borders
with Guatemala and El Salvador to the west and south, respectively. The WRH referral area
includes the four states (Copán, and parts of Ocotopeque, Lempira, Santa Barbara); each
state is comprised of municipalities (municipios), each with an average extent of
approximately 400 km2. The region has modest geographic isolation, wherein most health
care is local, and with limited transit to the two metropolitan centers in Honduras, San Pedro
Sula (northern industrial capital) and Tegucigalpa (central governmental capital).
National Census data
The official census and population data was obtained from the Honduras National Statistics
Institute (Instituto Nacional de Estadistica or INE). The most recent national census was in
2001. INE also provides precise estimates of annual population growth, specific for age,
gender, and geopolitical divisions (e.g., village, municipality). We used the most recent
projections for the non-census years of the current study, which were released in 2009.
Catchment area analysis
The catchment area for gastroenterology services for the Western Regional Hospital was
delineated by calculation of upper endoscopy utilization rates during the study decade. The
detailed WRH endoscopy database was used, which contained de-identified information on
all patients undergoing for endoscopy in the Western Regional Hospital. This database
included information on patient age, sex, and village and municipality of origin.
We calculated the crude upper endoscopy utilization rates (EUR), expressed per 100,000
person-years, for each municipality in western Honduras over the ten year period to validate
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the catchment area for gastroenterology services of the WRH, and in turn the definitive at-
risk population for the incident cases of gastric cancer within the catchment area. Endoscopy
utilization rates were estimated for each municipality in the four western states of Honduras
(Copán, Ocotopeque, Lempira, Santa Barbara). The 2001 census population of each
municipality was used for calculation of the crude rates.
Using the state of Copán as a reference, we first identified the range of municipality-specific
endoscopy utilization rates within the state of Copán in which the district hospital is located.
We then verified whether these rates followed a normal distribution. An evident threshold of
30 endoscopies per 100,000 person-years was observed in Copán. This threshold was used
to identify municipalities from the 3 neighboring states to include in the analysis and thus
demarcate the WRH catchment area for endoscopy services. In general, the excluded
municipalities (i.e., EUR <30 per 106 person-years) pertained to neighboring regional health
districts. This includes the municipalities located near the borders with El Salvador and
Guatemala, whose residents may receive medical care in the neighboring countries. The
Central America Integration System (SICA) for the four countries permits health care in the
neighboring countries in the public and private sectors, regardless of nationality [personal
communication, Dra. Maria Rodriguez, Minister of Health, El Salvador, May 31, 2012].
Gastric cancer case ascertainment
We utilized the comprehensive endoscopy database of all noncardia gastric adenocarcinoma
cases presenting to the Western Regional Hospital (WRH) for identification of incident
cases 2000–2009. All patients who presented were symptomatic, with indications for
endoscopy. A unique identification code prevented duplicate case entry.
Historically, the Honduras Ministry of Health has been unable to finance pathology services
in the majority of public hospitals in Honduras, including the Western Regional Hospital.
Patients are asked to pay out-of-pocket if they are able, and the majority of patients are
unable to do so, leaving most without a final diagnosis anchored with pathology. An
ongoing prospective gastric cancer case-control study based at the WRH (NIH CA1255884,
DRM), has had the secondary clinical benefit of providing pathology results for many
subjects in recent years during the 2000–2009 period. When pathology results were
available, these were included in the overall database, and were used to confirm case
identification. In cases where biopsy was not performed or pathology was non-diagnostic
(e.g. necrotic material from a mass lesion), the endoscopic diagnosis was considered final.
The database also provided clinical data such as the endoscopy appearance (e.g., Borrmann
classification). Similarly, cross-sectional imaging is generally unavailable; pyloric
obstruction was used as a surrogate for advanced disease.
Age standardized incidence rate calculations
Crude incidence rates were calculated for males and females by both age group and by
municipality. Age standardized incidence rates (ASIRs) were calculated using the world
standard population fractions for the five age groups: 0–14, 15–44, 45–54, 55–64, and over
65 [12]. The ASIRs were calculated for each year, as well as for the decade. As noted, the




The crude upper endoscopy utilization rate (EUR) with the utilization threshold of 30 per
100,000 person-years was used to delineate the at-risk base population served by the
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Western Regional Hospital. Of the 95 municipalities in the 4 states of western Honduras, 40
municipalities had an EUR greater than 30 for validation of the catchment area. Nearly all
municipalities within the state of Copán were included (22/23), with the exception of one
municipality on the border with Guatemala. In the other 3 states, 18 municipalities met the
threshold criteria for inclusion: Lempira (5/28), Ocotepeque (8/16), and Santa Barbara
(5/28); in Santa Barbara, located in the north, 18 of the 23 excluded municipalities did not
have endoscopy referrals during the study decade. In parallel, WRH physician expert
opinion, blinded to the analysis, generated an independent list of municipalities of the WRH
referral area; near-complete agreement was noted, as the EUR analysis included two
additional municipalities, and excluded only one from the physician generated list.
In the study decade, a total of 3936 endoscopies were performed at the Western Regional
Hospital, of which 3431 (87%) pertained to municipalities in the validated catchment area.
Of the 3431 total endoscopies in the referral area, a reasonable balance of endoscopy volume
was observed among the municipalities in the states neighboring Copán (69%): Lempira
(11.0%), Ocotepeque (9.0%), and Santa Barbara (11.0%). In the catchment area over the
decade, the mean crude EUR was 63.5 and 131.6 per 106 person-years, for all residents and
for all adults age 20 or older, respectively.
Age standardized incidence rates
In Western Honduras catchment area, during the decade 2000–2009, a total of 670 incident
cases of incident gastric adenocarcinoma cases were diagnosed, of whom 439 were male
(65.5%) and 231 were female (34.5%). An estimated 5.1 endoscopies were performed for
each new diagnosis of gastric cancer. We observed 67 (10.0%) and 165 (24.6%) of cases
under the ages of 45 and 55, respectively. The crude gender-specific rates were 28.1 per 106
person-years for males and 14.0 per 106 person-years for females. (Table 1). When stratified
by age, the highest crude incidence was in persons 65 years and older: 233.4 and 93.9 per
106 person-years for males and females, respectively. In the 10 year period of this analysis,
the annual standardized incidence rates per 106 population (ASIRs) were 30.8 for males and
13.9 for females. (Table 2). The ASIRs of gastric cancer were fairly stable during the study
decade, with modest annual variability (range for males, 25.2–39.8, and for females, 9.4–
22.5). Stratification by municipality identified eight municipalities with higher male gastric
cancer incidence rates, thereby highlighting areas for prevention programs and/or
epidemiology investigation.
There were an additional 139 incident cases of gastric cancer diagnosed by endoscopy at the
Western Regional Hospital in the period 2000–2009, for patients residing in municipalities
outside of the validated catchment area, ie, from municipalities pertaining to other health
districts for gastroenterology services. These comprised 17.2% (139/809) of the total
number of gastric cancer cases, which was similar to the percent of endoscopy volume
12.8% (505/3936) from these areas. The demographic and clinical characteristics of patients
from municipalities outside of the catchment area were similar (data not shown); one
difference was noted: males ages 55–64 formed a higher percentage of total cases (35.2%,
versus 26.2% in the catchment area).
Clinical characteristics of gastric cancer cases
The clinical characteristics of the incident gastric adenocarcinoma cases underscore the
reality of advanced disease at the time of diagnosis for the majority of patients in the region.
All patients were symptomatic at the time of presentation and endoscopy. As noted, the
case-finding rate was 5.1 upper endoscopies per new diagnosis. The most frequent gross
endoscopic appearance of gastric cancers was Borrmann type 3 (ulcerated mass), which
represented 60.3% of cases. (Table 3). Pyloric obstruction was a common presentation,
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35.2% (236/670) overall, of whom 16.6% and 18.7% were completely and incompletely
obstructed, respectively.
Definitive pathology was available for 526 of the 670 subjects. The histology by the Lauren
classification was distributed among the diffuse (56%), intestinal (34%) and indeterminate
(9.9%). The age and sex distribution of the incident gastric cancer cases by histologic
subtype was not statistically different from the overall distribution in Table 1. In the 144
subjects without definitive pathology, 14.1% (95/670) did not have biopsies performed,
including 24 patients proceeded directly to surgery.7.3% (49/670) of patients had
inconclusive histology, the majority of whom had histology demonstrating ulceration or
necrotic material associated with a mass lesion (e.g., Borrmann type 1, 2, 3), wherein the
specificity of endoscopic features approaches 100%. Cases with the following features at
endoscopy were conservatively excluded from the analysis: early gastric cancers, flat lesions
(e.g., Borrman IV), and benign-appearing gastric ulcers. As indicated, pathology services are
not financed through the government, and the majority of the financing has been facilitated
by an ongoing gastric cancer initiative at the locale (NIH CA1255884, DRM). In summary,
these clinical findings echo the IARC data which show nearly equal incidence and mortality
rates, suggesting that patients present relatively late and have limited therapeutic options in
this resource limited setting of Central America.
DISCUSSION
A high incidence of gastric cancer is observed in western Honduras, facilitated by
methodology using a detailed endoscopy database to compliment regional cancer and
pathology data, and thereby serve as a cancer registry surrogate in the absence of a national
cancer registry. The incidence rates we have calculated for this region rival other known
high incidence countries in Latin America such as Costa Rica and Chile. The incidence rates
for the past decade in Western Honduras (ASIRs of 30.8 and 13.9 per 106 person-years for
males and females, respectively) are substantially higher than the IARC (GLOBOCAN
2002: ASIRs of 15.2 and 10.8 per 106 person-years for males and females, respectively)
estimates for Honduras which were available at the time of study initiation. The gastric
cancer incidence estimates herein have been presented in preliminary form for earlier
periods (e.g., 1996–2000) [7], which has served to provide input for the more recent IARC
estimates (GLOBOCAN 2008: ASIRs of 31.4 and 25.9 for males and females, respectively)
[2].
Unbiased estimates of incidence rates require accuracy of both numerator (case
ascertainment) and denominator (corresponding at-risk population) data. In resource-limited
settings where pathology services and cancer registry data are often unavailable, accurate
incidence data are difficult to capture. In addition, in many low income countries, large
capital cities suffer from significant immigration from the rural areas, and often do not have
the infrastructure to document incident cases in the urban public and private health care
sectors. This study took advantage of a unique geopolitical and logistical model to improve
upon previous approximations imputed from Central American as a whole.
The study of endoscopy utilization is useful for trend and resource allocation analyses in
high income countries [13,14]. In resource-limited nations, the use of a comprehensive
endoscopy registry may serve as a complimentary methodology for gastrointestinal cancer
registries. We used the endoscopy database both to validate the at-risk population by
calculation of endoscopy utilization (endoscopy “incidence”) in the area, and for gastric
adenocarcinoma case ascertainment. This may be a useful tool in similar developing nation
environments, in order to streamline public health and prevention programs, given the
predicted growth in the global cancer burden. In addition, the estimation of incidence rates
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at the level of each municipality, albeit subject to imprecision due to the smaller number of
cases, could help focus prevention programs to specific municipalities or states within a
given country.
In spite of our detailed methodology, the study likely underestimates the incidence of gastric
cancer in Western Honduras for several reasons. First, in the absence of a formal screening
program for gastric cancer, only symptomatic cases are evident, and all asymptomatic cases
will remain undiagnosed and unreported. Second, in the impoverished rural areas,
symptomatic patients may not present to medical facilities and expire at home; this may be
due to transportation difficulties (e.g., rainy season), or cultural issues (e.g., suspicion of
hospitals) [15]. This phenomenon would be expected to affect rates among older subjects in
particular. A verbal autopsy program conducted by social promoters could help in this
regard. [16,17] Third, in this rural area, there is modest flux of patients to medical facilities
outside of the catchment area for specialty services. A percentage of patients residing in the
western, southern and northeastern municipalities of the catchment areas, may seek care in
the urban centers in neighboring Guatemala, El Salvador, and northern Honduras (San Pedro
Sula), respectively. Importantly, there is no appreciable flow of into the public district
hospital of Western Honduras from these urban areas. Thus, the incidence estimates herein
are conservative. Lastly, natural disasters and political events may affect regional health.
During the political turmoil in Honduras in the latter half of 2009, strict curfews and
highway closures were commonplace, which affected access to health care. For example, a
50% decrease in endoscopy volume was observed in 2009 for patients from the state of
Santa Barbara, which may in part explain the lower ASIR for males in 2009.
In conclusion, an endoscopy database may serve as a complimentary data resource and
methodology for gastric cancer incidence estimations in resource-limited nation settings
wherein cancer registries are nonexistent or unreliable. The gastric cancer incidence rates for
western Honduras are substantially higher than the international estimates at the time of
study initiation, and helped provide data for the more accurate recent estimates, in spite of
conservative methods and probable underestimation. These results help more fully
characterize the high incidence of gastric cancer in western Honduras and this region of
Central America, and demonstrate the need for additional epidemiologic research and
interventions focused on prevention and treatment.
Acknowledgments
The authors wish to express gratitude for the support from the following individuals and institutions: Hospital de
Occidente and Ministry of Health (Carmen Ramos, Gloria Fajardo, Aidé Hernandez), Central American Medical
Outreach (Kathy Tschiegg, Director; Lesby Castellanos, Bairon Moreno), Pathology (Francisco Herrera, Amado
Rodriguez), Research assistance (Natalie Prichett, Suvi Gross, Elaine Smith, Michael Clark-Pearson), and the city
of Santa Rosa de Copan (Juan Carlos Elvir, Mayor).
Financial support: This study was supported in part by grants from the National Institutes of Health: P30 DK
034987, T32 DK07634 (SC, JL), and CA1255884 (DRM).
References
1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: a cancer
journal for clinicians. 2011; 61(2):69–90.10.3322/caac.20107 [PubMed: 21296855]
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of
cancer in 2008: GLOBOCAN 2008. International journal of cancer Journal international du cancer.
2010; 127(12):2893–2917.10.1002/ijc.25516 [PubMed: 21351269]
3. de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, Plummer M. Global burden of
cancers attributable to infections in 2008: a review and synthetic analysis. The lancet oncology.
2012; 13(6):607–615.10.1016/S1470-2045(12)70137-7 [PubMed: 22575588]
Dominguez et al. Page 7













4. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020:
Global Burden of Disease Study. Lancet. 1997; 349(9064):1498–1504.10.1016/
S0140-6736(96)07492-2 [PubMed: 9167458]
5. de Sablet T, Piazuelo MB, Shaffer CL, Schneider BG, Asim M, Chaturvedi R, Bravo LE, Sicinschi
LA, Delgado AG, Mera RM, Israel DA, Romero-Gallo J, Peek RM Jr, Cover TL, Correa P, Wilson
KT. Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk. Gut.
2011; 60(9):1189–1195.10.1136/gut.2010.234468 [PubMed: 21357593]
6. Con SA, Takeuchi H, Con-Chin GR, Con-Chin VG, Yasuda N, Con-Wong R. Role of bacterial and
genetic factors in gastric cancer in Costa Rica. World journal of gastroenterology: WJG. 2009; 15
(2):211–218. [PubMed: 19132772]
7. Morgan DR, Dominguez RL, Keku TO, Heidt PE, Martin CF, Galanko JA, Omofoye OA, Sandler
RS. Gastric cancer and the high combination prevalence of host cytokine genotypes and
Helicobacter pylori in Honduras. Clinical gastroenterology and hepatology: the official clinical
practice journal of the American Gastroenterological Association. 2006; 4(9):1103–1111.10.1016/
j.cgh.2006.05.025 [PubMed: 16820326]
8. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA: a cancer journal for
clinicians. 2005; 55 (2):74–108. [PubMed: 15761078]
9. Agha A, Graham DY. Evidence-based examination of the African enigma in relation to
Helicobacter pylori infection. Scandinavian journal of gastroenterology. 2005; 40(5):523–
529.10.1080/00365520510012280 [PubMed: 16036504]
10. Valsecchi MG, Steliarova-Foucher E. Cancer registration in developing countries: luxury or
necessity? The lancet oncology. 2008; 9(2):159–167.10.1016/S1470-2045(08)70028-7 [PubMed:
18237850]
11. Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human
Development Index (2008–2030): a population-based study. The lancet oncology. 201210.1016/
S1470-2045(12)70211-5
12. Bray F, Guilloux A, Sankila R, Parkin DM. Practical implications of imposing a new world
standard population. Cancer causes & control: CCC. 2002; 13 (2):175–182. [PubMed: 11936824]
13. Sonnenberg A, Amorosi SL, Lacey MJ, Lieberman DA. Patterns of endoscopy in the United
States: analysis of data from the Centers for Medicare and Medicaid Services and the National
Endoscopic Database. Gastrointest Endosc. 2008; 67(3):489–496.10.1016/j.gie.2007.08.041
[PubMed: 18179793]
14. Westbrook JI. Trends in the utilization of diagnostic upper GI endoscopy in New South Wales,
Australia, 1988 to 1998. Gastrointest Endosc. 2002; 55 (7):847–853. [PubMed: 12024139]
15. Grimes CE, Bowman KG, Dodgion CM, Lavy CB. Systematic review of barriers to surgical care
in low-income and middle-income countries. World journal of surgery. 2011; 35(5):941–
950.10.1007/s00268-011-1010-1 [PubMed: 21360305]
16. Dikshit R, Gupta PC, Ramasundarahettige C, Gajalakshmi V, Aleksandrowicz L, Badwe R, Kumar
R, Roy S, Suraweera W, Bray F, Mallath M, Singh PK, Sinha DN, Shet AS, Gelband H, Jha P.
Cancer mortality in India: a nationally representative survey. Lancet. 2012; 379(9828):1807–
1816.10.1016/S0140-6736(12)60358-4 [PubMed: 22460346]
17. Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ, Naghavi M.
Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet.
2011; 378(9801):1461–1484.10.1016/S0140-6736(11)61351-2 [PubMed: 21924486]
Dominguez et al. Page 8

































































































































































































































































































































































































































































































































































































































































































































Dominguez et al. Page 11
Table 3
Clinical characteristics of gastric cancer, Western Honduras, 2000–2009
Endoscopy summary N/n
Endoscopies performed 5.1
per incident gastric cancer (3431/670)
Borrmann classification (N= 670) n (%)
Type 1 (polypoid) 6 (0.9%)
Type 2 (fungating mass) 64 (9.6%)
Type 3 (ulcerated mass) 404 (60.3%)
Type 4 (diffuse infiltrative) 48 (7.2%)
Type 5 (unclassified, not 1–4) 101 (15.1%)
Unknown 47 (7.0)
Pyloric obstruction (N= 670) n (%)
Total (incomplete or complete) 236 (35.2%)
 Incomplete 125 (18.7%)
 Complete 111 (16.6%)
None 434 (64.8%)





The Honduras Ministry of Health does not finance pathology services for the regional hospitals; available pathology has been financed by external
sources.
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